This compound is a pharmaceutical intermediate used in the manufacturing process of pirtobrutinib. It features an amide linkage, two aromatic rings, ether groups, a fluorine atom, and nitrile groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-(4-(2,2-Dicyano-1-hydroxyvinyl)benzyl)-5-fluoro-2-methoxybenzamide
pharmaceutical intermediate
7-(3-Chloropropyl)theophylline
pharmaceutical intermediate
Methyl 4-(trifluoromethyl)cyclohexane-1-carboxylate
pharmaceutical intermediate
Methyl 4-(trifluoromethyl)cyclohexane-1-carboxylate
pharmaceutical intermediate
[3-(Dimethylamino)propyl]triphenylphosphonium bromide hydrobromide
pharmaceutical intermediate
4-[[(5-Fluoro-2-methoxybenzoyl)amino]methyl]benzoic acid
pharmaceutical intermediate
Methyl (2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate
pharmaceutical intermediate
N-Desmethyl Itopride Hydrochloride
pharmaceutical raw material
N-[[4-(2,2-dicyano-1-methoxyethenyl)phenyl]methyl]-5-fluoro-2-methoxybenzamide
AAXZFPXUWCCTBX-UHFFFAOYSA-N
COC1=C(C=C(C=C1)F)C(=O)NCC2=CC=C(C=C2)C(=C(C#N)C#N)OC
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.